Please login to the form below
Movymia
This page shows the latest Movymia news and features for those working in and with pharma, biotech and healthcare.
CHMP recommends Merck & Co's Lantus biosimilar
Hungarian pharmaceutical firm Gedeon Richter and Germany's Stada Arzneimittel received recommendations for Terrosa and Movymia respectively, for the treatment of postmenopausal women and men at increased risk of fracture.
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- Embattled Biogen talks up Aduhelm
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Live Webinar: Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Queen's Award Highlights Video
- Innovative Trials wins the Queen’s Award
- Will most electronic consumer goods turn into medical devices after the MDR?
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- Biogen’s Vumerity recommended by CHMP in MS
- David Hunt launches independent agency The Considered
- WHO to test three more potential COVID-19 treatments
- Congress “concerned by apparent anomalies” around FDA’s approval of Aduhelm
- FDA clears BMS/AZ's dapagliflozin at second attempt
- Why you should feel optimistic about the future of healthcare
- Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups
PMHub
Innovative Trials
Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...
Latest intelligence
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
